Harrison SR - Search Results

1

Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.

Zhao SS, Harrison SR, Chan A, Clarke N, Davis C, Eddison J, Gregory WJ, Jones GT, Marzo-Ortega H, Murphy DJ, Sandhu V, Sengupta R, Siebert S, Thompson B, Webb D, Yates M, Gaffney K. Zhao SS, et al. Among authors: harrison sr. Rheumatol Adv Pract. 2023 May 15;7(2):rkad039. doi: 10.1093/rap/rkad039. eCollection 2023. Rheumatol Adv Pract. 2023. PMID: 37197377 Free PMC article. Review.

2

Harrison SR, Burska AN, Emery P, Marzo-Ortega H, Ponchel F. Harrison SR, et al. Rheumatology (Oxford). 2021 Aug 2;60(8):3607-3616. doi: 10.1093/rheumatology/keaa817. Rheumatology (Oxford). 2021. PMID: 33393636

3

Chest pain mimicking pulmonary embolism may be a common presentation of COVID-19 in ambulant patients without other typical features of infection.

Harrison SR, Klassen JRL, Bridgewood C, Scarsbrook A, Marzo-Ortega H, McGonagle D. Harrison SR, et al. J Intern Med. 2021 Aug;290(2):349-358. doi: 10.1111/joim.13267. Epub 2021 Mar 13. J Intern Med. 2021. PMID: 33560545 Free PMC article.

4

Subjective loss of clinical response to TNFi in axSpA relates to recurrence of MRI bone marrow oedema particularly with long-acting agents.

Harrison SR, Ansell R, Mathieson HR, Merashli M, Busquets-Pérez N, McGonagle D, Marzo-Ortega H. Harrison SR, et al. Rheumatology (Oxford). 2022 Apr 18;61(SI):SI86-SI91. doi: 10.1093/rheumatology/keab571. Rheumatology (Oxford). 2022. PMID: 34273162

5

Ixekizumab: an IL-17A inhibitor for the treatment of axial Spondylarthritis.

Harrison SR, Marzo-Ortega H. Harrison SR, et al. Expert Rev Clin Immunol. 2021 Oct;17(10):1059-1071. doi: 10.1080/1744666X.2021.1970534. Epub 2021 Aug 26. Expert Rev Clin Immunol. 2021. PMID: 34407705 Review.

6

Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1).

Harrison SR, Garrido-Cumbrera M, Navarro-Compán V, Correa-Fernández J, Webb D, Christen L, Marzo-Ortega H. Harrison SR, et al. Rheumatol Adv Pract. 2021 Dec 4;5(3):rkab098. doi: 10.1093/rap/rkab098. eCollection 2021. Rheumatol Adv Pract. 2021. PMID: 34988357 Free PMC article.

7

Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?

Harrison SR, Marzo-Ortega H. Harrison SR, et al. Curr Rheumatol Rep. 2023 Mar;25(3):56-67. doi: 10.1007/s11926-023-01097-7. Curr Rheumatol Rep. 2023. PMID: 36652160 Free PMC article. Review.

8

Correction to: Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?

Harrison SR, Marzo-Ortega H. Harrison SR, et al. Curr Rheumatol Rep. 2023 Jun;25(6):117. doi: 10.1007/s11926-023-01101-0. Curr Rheumatol Rep. 2023. PMID: 37010705 Free PMC article. No abstract available.

9

Real-world data provide insights into PsA treatment patterns.

Marzo-Ortega H, Harrison SR. Marzo-Ortega H, et al. Among authors: harrison sr. Nat Rev Rheumatol. 2023 Aug;19(8):466-467. doi: 10.1038/s41584-023-00965-x. Nat Rev Rheumatol. 2023. PMID: 37059913 No abstract available.

10

Time to address the challenge of difficult to treat psoriatic arthritis: results from an international survey.

Marzo-Ortega H, Harrison SR, Nagy G, Machado PM, McGonagle DG, Aydin SZ, Almodovar-González R, Bautista-Molano W, Gossec L, Lubrano E, Nash P, Pimentel Santos F, Soriano ER, Siebert S. Marzo-Ortega H, et al. Among authors: harrison sr. Ann Rheum Dis. 2024 Feb 15;83(3):403-404. doi: 10.1136/ard-2023-225087. Ann Rheum Dis. 2024. PMID: 37963707 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page